NASDAQ:AGRX - Agile Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$0.78 +0.02 (+2.63 %)
(As of 01/17/2019 02:00 AM ET)
Previous Close$0.76
Today's Range$0.75 - $0.78
52-Week Range$0.23 - $3.92
Volume80,700 shs
Average Volume197,700 shs
Market Capitalization$26.81 million
P/E Ratio-0.85
Dividend YieldN/A
Beta-0.16

Analyst Ratings

Agile Therapeutics (NASDAQ:AGRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Agile Therapeutics in the last 12 months. Their average twelve-month price target is $3.3333, suggesting that the stock has a possible upside of 327.35%. The high price target for AGRX is $4.00 and the low price target for AGRX is $3.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.002.712.672.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.3333$3.75$4.00$6.25
Price Target Upside: 327.35% upside362.96% upside381.93% upside805.80% upside

Agile Therapeutics (NASDAQ:AGRX) Consensus Price Target History

Price Target History for Agile Therapeutics (NASDAQ:AGRX)

Agile Therapeutics (NASDAQ:AGRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/11/2019HC WainwrightReiterated RatingBuy$4.00MediumView Rating Details
11/29/2018Maxim GroupInitiated CoverageBuy ➝ Buy$3.00HighView Rating Details
5/21/2018Royal Bank of CanadaLower Price TargetOutperform$3.00HighView Rating Details
3/14/2018Noble FinancialReiterated RatingBuyHighView Rating Details
12/28/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLowView Rating Details
12/26/2017William BlairDowngradeOutperform ➝ Market PerformHighView Rating Details
12/22/2017Cantor FitzgeraldReiterated RatingBuy$5.00HighView Rating Details
3/11/2017FBR & CoSet Price TargetBuy$10.00LowView Rating Details
(Data available from 1/17/2017 forward)
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel